Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rajkumar

Showing results (181-190 of 196) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|June 23, 2016
Natural history of amyloidosis isolated to fat and bone marrow aspirateRajshekhar Chakraborty, Morie A Gertz, Angela Dispenzieri, et al.
American Journal of Hematology|October 8, 2008
A novel report of cig-FISH and cytogenetics in POEMS syndromeAlan H Bryce, Rhett P Ketterling, Morie A Gertz, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen typeEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Nature Communications|December 5, 2018
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progressionArianna Calcinotto, Arianna Brevi, Marta Chesi, et al.
American Journal of Hematology|February 19, 2019
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosisM Hasib Sidiqi, Surendra Dasari, Ellen D McPhail, et al.
American Journal of Hematology|December 16, 2020
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myelomaJoselle Cook, Isla Johnson, Alexandra Higgins, et al.
Haematologica|May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic responseMatthew J Rees, Susan Geyer, Binoy Yohannan, et al.
Bone Marrow Transplantation|August 9, 2018
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete responseM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Research Square|March 27, 2026
Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple MyelomaNadine Abdallah, Byron Smith, Thomas White, et al.
Blood Cancer Journal|May 8, 2020
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?M Hasib Sidiqi, Mohammed Aljama, Shaji K Kumar, et al.
Pageof 20

Showing results (181-190 of 196) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|June 23, 2016
Natural history of amyloidosis isolated to fat and bone marrow aspirateRajshekhar Chakraborty, Morie A Gertz, Angela Dispenzieri, et al.
American Journal of Hematology|October 8, 2008
A novel report of cig-FISH and cytogenetics in POEMS syndromeAlan H Bryce, Rhett P Ketterling, Morie A Gertz, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen typeEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Nature Communications|December 5, 2018
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progressionArianna Calcinotto, Arianna Brevi, Marta Chesi, et al.
American Journal of Hematology|February 19, 2019
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosisM Hasib Sidiqi, Surendra Dasari, Ellen D McPhail, et al.
American Journal of Hematology|December 16, 2020
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myelomaJoselle Cook, Isla Johnson, Alexandra Higgins, et al.
Haematologica|May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic responseMatthew J Rees, Susan Geyer, Binoy Yohannan, et al.
Bone Marrow Transplantation|August 9, 2018
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete responseM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Research Square|March 27, 2026
Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple MyelomaNadine Abdallah, Byron Smith, Thomas White, et al.
Blood Cancer Journal|May 8, 2020
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?M Hasib Sidiqi, Mohammed Aljama, Shaji K Kumar, et al.
Pageof 20